Skip to main content
EMBC logo

EMBC · Embecta Corp. · Investor Relations

Track EMBC — free
$6.16 +0.01 (+0.08%) Play latest call Q3 2026 earnings call transcript
Market Cap
$348.46M
Shares
56.66M
Volume · Nov 18 198.47K Avg daily vol (3M) 1.04M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-31 embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor

2026-08-07 Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported third quarter fiscal 2026 financial results.

2026-08-07 embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 15, 2026 to stockholders

2026-07-23 embecta to Report Fiscal Third Quarter Financial Results

PARSIPPANY, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2026 financial

2026-06-16 embecta appoints Nimish Muzumdar as SVP and President, North America

PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that Nimish Muzumdar has been named the company’s Senior Vice

2026-06-01 embecta to Participate in Investor Events

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor

2026-05-15 embecta Completes Acquisition of Owen Mumford Holdings Limited

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held, UK-based

2026-05-08 embecta to Participate at the 2026 BofA Securities Global Health Care Conference

PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.

2026-05-05 Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter fiscal 2026 financial results.

2026-05-05 embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.01 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 15, 2026 to stockholders of

2026-04-21 embecta to Report Fiscal Second Quarter Financial Results

PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial

2026-03-19 embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and accelerate transformation into a broad‑based medical supplies company PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Embecta Corp.

2026-02-11 embecta names new Chairman of the Board and Lead Independent Director

PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Board of Directors (the “Board”) of embecta has elected

2026-02-05 Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.

Past events

Date Event Type
2026-09-10 J.P. Morgan 4th Annual Nashville Healthcare Conference 2026 Conference
2026-09-09 Wells Fargo 2026 Healthcare Conference Conference
2026-08-07 Embecta Third Quarter of Fiscal Year 2026 Earnings Conference Call Earnings call
2026-05-13 BofA Securities 2026 Global Healthcare Conference Conference
2026-05-05 Embecta Second Quarter of Fiscal Year 2026 Earnings Conference Call Earnings call
2026-02-05 Embecta First Quarter of Fiscal Year 2026 Earnings Conference Call Earnings call
2026-01-14 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-25 Embecta Fourth Quarter of Fiscal Year 2025 Earnings Conference Call Earnings call
2025-09-04 2025 Wells Fargo Healthcare Conference Conference
2025-08-08 Embecta Third Quarter of Fiscal Year 2025 Earnings Conference Call Earnings call
2025-06-10 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-05 2025 Jefferies Global Healthcare Conference Conference
2025-05-22 Embecta Analyst & Investor Day Presentation

Source: https://investors.embecta.com/

Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 341 filings 288 filers Visit website Investor relations